Immediate Impact
1 by Nobel laureates 4 from Science/Nature 59 standout
Citing Papers
Type 1 diabetes
2023 Standout
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes
2023 Standout
Works of James W. Lynch being referenced
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma
1999
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| James W. Lynch | 651 | 451 | 181 | 274 | 34 | 1.1k | |
| Cathrin Skrabs | 646 | 358 | 137 | 337 | 40 | 1.1k | |
| J. M. Vose | 776 | 582 | 196 | 281 | 30 | 1.2k | |
| Manuel Gotti | 789 | 362 | 239 | 376 | 36 | 959 | |
| Astrid Franke | 631 | 397 | 140 | 384 | 27 | 1.0k | |
| S Pileri | 441 | 327 | 131 | 206 | 35 | 1.3k | |
| Irène Biasoli | 690 | 611 | 176 | 162 | 44 | 1.2k | |
| M. Engelhard | 712 | 632 | 121 | 262 | 39 | 1.2k | |
| Silvia Franceschetti | 730 | 363 | 234 | 407 | 45 | 1.2k | |
| Mars B. van ’t Veer | 524 | 350 | 137 | 277 | 36 | 1.4k | |
| TA Lister | 523 | 397 | 104 | 306 | 32 | 1.0k |
All Works
Loading papers...